About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

What You Need to Know About GLP-1 Weight-Loss Drugs Now That the FDA Says the Shortage Is Over

By: NewsUSA

(NewsUSA) - Consumers are urged to understand which GLP-1 medications are safe, approved, and legal after May 22

If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ask yourself, “What’s real, what’s safe, and what should I avoid?”

In 2022, growing demand combined with limited supply created a shortage of these GLP-1 medications. In response to this shortage, the U.S. Food and Drug Administration (FDA) permitted licensed compounding pharmacies to fill this gap and create non-FDA-approved “compounded” versions of these products. These unapproved products lack the assurances of safety and effectiveness that come with FDA-approved medicines and were only intended as a temporary fix during the shortage.  But bad actors have used the temporary shortage to mass market untested, unapproved products and even products that are meant for “research purposes only.”

Fortunately, the FDA declared the national shortage of GLP-1 medications over and said compounding pharmacies must stop mass producing and selling these compounded medications after May 22, 2025. However, the marketing of compounded and other risky, illegal weight loss products is expected to continue—leaving patients who are working hard to manage chronic diseases like obesity without a clear understanding of the facts.

Patient confusion is already a serious issue and is likely to intensify in the coming months.  A new national survey by the National Consumers League (NCL) found that widespread confusion already exists among women: more than 70% believe compounded GLP-1s are only on the market if they have been tested and proven safe, and more than half (53%) think compounded GLP-1s have received FDA approval. Neither of these claims is true.

Here are five things consumers should know to protect themselves:

  1. Mass Compounded GLP-1s Are Not Supposed to be on the Market after May 22
    While only products that are “FDA-approved” and are prescribed by a medical professional are supposed to be on the market, consumers will still have to beware of fake ads, sites, and GLP-1s. The statement “doctor approved” is a red flag.
  2. Only FDA-Approved GLP-1s Are Proven Safe and Effective
    FDA-approved drugs undergo clinical trials to ensure they are safe and effective. Compounded alternatives do not and they also pose more potential risks to patients.
  3. If It’s a Gummy, Chewable, Spray, Patch, or Under-the-Tongue Form, It’s Fake
    Be wary of products that claim to be GLP-1s in forms other than an injection. These are very likely not FDA-approved medications and may be counterfeit.
  4. Don’t Fall for Misleading Marketing
    Slick websites and social ads can make unapproved medications, and even illicit drugs, seem like the real thing. But according to NCL’s research, 85 percent of women with obesity believe the false claims made in online non-brand GLP-1 ads. Protect yourself by sticking to trusted medical providers and learning how to spot false claims.
  5. Ask Questions and Stay Informed
    Not sure if your medication is the real thing? Ask your health care provider or company selling you the GLP-1 if it’s the FDA-approved brand product. You can also reach out to the FDA-approved manufacturers to determine whether you have authentic medicine.

Both the FDA and consumers have important roles to play in stopping the spread of misinformation about GLP-1 weight-loss drugs. Now that the shortage is over, the FDA must enforce the law and its long-standing standards for compounded products. Consumers can act too, by asking questions, avoiding questionable sources, and learning how to tell the difference between what’s FDA-approved, what’s fake, and what’s a risk.

To report fake GLP-1s or learn more about how to protect yourself, check out guidance from the National Consumers League.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.